Content about Organ transplants

December 10, 2012
FDA grants Astellas NDA for tacrolimus extended-release capsules

Astellas Pharma US has announced the Food and Drug Administration's approval to review the new drug application for tacrolimus extended-release capsules.

NORTHBROOK, Ill. — Astellas Pharma US announced the Food and Drug Administration's review of their new drug application for tacrolimus extended-release capsules, a once-daily formulation of the calcineurin-inhibitor immunosuppressant tacrolimus, for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients.

September 26, 2012
Astellas applies for FDA approval of organ transplant drug

The U.S. subsidiary of Japanese drug maker Astellas is seeking approval from the Food and Drug Administration for a drug to prevent rejection of transplanted organs.

NORTHBROOK, Ill. — The U.S. subsidiary of Japanese drug maker Astellas is seeking approval from the Food and Drug Administration for a drug to prevent rejection of transplanted organs.

Astellas Pharma US said it applied with the FDA for approval of tacrolimus extended-release capsules to prevent rejection of transplanted kidneys in adults and transplanted livers in men. The drug was approved in Europe in 2007 under the name Advagraf and under the name Graceptor in Japan in 2008; the drug has been approved in 69 countries so far.

May 14, 2012
Schnucks opens specialty pharmacy at Illinois hospital

Schnuck Markets is opening a stand-alone pharmacy at a hospital in Illinois with an emphasis on specialty pharmacy services, the supermarket operator said.

SPRINGFIELD, Ill. — Schnuck Markets is opening a stand-alone pharmacy at a hospital in Illinois with an emphasis on specialty pharmacy services, the supermarket operator said.

Schnucks said the 2,000-sq.-ft. pharmacy at the pavilion of St. John's Hospital in Springfield, Ill., would be its first stand-alone specialty pharmacy in Illinois, specializing in such conditions as HIV, hepatitis, autoimmune disorders, organ transplants and cancers. The pharmacy replaces the specialty pharmacy at a nearby store, though the store's traditional pharmacy will remain.